Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH) 11 - 15 July 2026

FVIIIa-mimetic bispecific antibody (Mim8) enhances thrombus formation of von Willebrand disease (VWD) under high shear flow condition.

Authors :

Hiroaki Yaoi¹, Kenichi Ogiwara¹, Yuto Nakajima¹, Keiji Nogami¹, Hiromi Okada², Jacob Lund³

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Rare Blood Disorders

Congress poster

Mim8

Search Science Hub

Are you a healthcare professional?

FVIIIa-mimetic bispecific antibody (Mim8) enhances thrombus formation of von Willebrand disease (VWD) under high shear flow condition.​

FVIIIa-mimetic bispecific antibody (Mim8) enhances thrombus formation of von Willebrand disease (VWD) under high shear flow condition.